EconPapers    
Economics at your fingertips  
 

Health care spending in the US vs UK: The roles of medical education costs, malpractice risk and defensive medicine

Michael Keane (), Barry McCormick and Gosia Popławska

European Economic Review, 2020, vol. 124, issue C

Abstract: We analyze how two key factors contribute to the high cost of healthcare in the US relative to the UK: (i) the higher private cost of medical education, and (ii) the higher risk of malpractice litigation. To assess the role of these factors we formulate, calibrate and simulate an equilibrium model of physician wages and the supply of medical graduates, work hours and treatment decisions of practicing physicians, and malpractice risk and malpractice insurance pricing. Consistent with prior work, we find direct costs of malpractice fines and insurance explain little of the high cost of healthcare in the US. However, the high private cost of medical education interacts with high malpractice risk in an interesting way: It leads doctors to (i) demand high wages and (ii) use excessive diagnostics to mitigate risk (“defensive medicine”). The agency problem that arises because patients cannot judge the efficacy of tests allows them to be over-prescribed. Together, these factors increase costs far more than direct malpractice costs. Specifically, physician salaries plus diagnostic tests comprise 4.04% of GDP in the US, compared to only 2.3% in the UK. The mechanisms emphasized in our model can largely explain the difference. Our policy simulations imply that more generous medical education subsidies would lead to both improved patient welfare and reduced overall health care costs in the US system (a Pareto improvement). We also find policies to (i) reduce malpractice risk, or (ii) induce doctors to internalize a small part of diagnostic costs, would have similar efficacious effects.

Keywords: Health care expenditure; Physician Supply and Demand; Medical education costs; Malpractice insurance; Defensive medicine; Graduate medical education; Diagnostic testing; Agency problem; Moral hazard (search for similar items in EconPapers)
JEL-codes: I13 D82 C34 C35 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0014292120300337
Full text for ScienceDirect subscribers only

Related works:
Working Paper: Health Care Spending in the US vs UK: The Roles of Medical Education Costs, Malpractice Risk and Defensive Medicine (2017) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:eecrev:v:124:y:2020:i:c:s0014292120300337

DOI: 10.1016/j.euroecorev.2020.103401

Access Statistics for this article

European Economic Review is currently edited by T.S. Eicher, A. Imrohoroglu, E. Leeper, J. Oechssler and M. Pesendorfer

More articles in European Economic Review from Elsevier
Bibliographic data for series maintained by Nithya Sathishkumar ().

 
Page updated 2021-04-17
Handle: RePEc:eee:eecrev:v:124:y:2020:i:c:s0014292120300337